[1]李 爽,王建民,胡沛霖.颈动脉支架植入术后血清长链非编码RNA结直肠肿瘤差异表达基因水平及临床意义 [J].介入放射学杂志,2021,30(07):707-710.
 LI Shuang,WANG Jianmin,HU Peilin..Serum long-chain non-coding RNA colorectal tumor differentially expressed level after carotid artery stenting and its clinical significance[J].journal interventional radiology,2021,30(07):707-710.
点击复制

颈动脉支架植入术后血清长链非编码RNA结直肠肿瘤差异表达基因水平及临床意义



()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
30
期数:
2021年07
页码:
707-710
栏目:
临床研究
出版日期:
2021-07-29

文章信息/Info

Title:
Serum long-chain non-coding RNA colorectal tumor differentially expressed level after carotid artery stenting and its clinical significance
作者:
李 爽 王建民 胡沛霖
Author(s):
LI Shuang WANG Jianmin HU Peilin.
Division I, Department of Neurology, Xingtai Municipal People’s Hospital, Xingtai, Hebei Province 054000, China
关键词:
【关键词】 颈动脉支架植入术 长链非编码RNA结直肠肿瘤差异表达基因 预后
文献标志码:
A
摘要:
【摘要】 目的 探讨颈动脉支架植入术后血清长链非编码RNA(LncRNA)结直肠肿瘤差异表达基因(CRNDE)水平及临床意义。 方法 选取2018年1月至2019年6月在邢台市人民医院接受颈动脉支架植入术治疗的173例颈动脉狭窄性急性缺血性脑卒中(AIS)患者作为研究对象。采用实时荧光定量聚合酶链反应(RT-qPCR)法检测患者血清LncRNA CRNDE相对表达量,并分析其与预后的关系。 结果 173例颈动脉狭窄性AIS患者支架植入术后预后不良发生率为39.88%(69/173)。预后不良组患者血清LncRNA CRNDE相对表达量为(1.35±0.34)%,显著高于预后良好组[(0.93±0.19)%](P<0.001)。Logistic回归分析显示,出血转化、脑卒中病灶数、LncRNA CRNDE与颈动脉狭窄性AIS患者预后关系密切。模型B(出血转化+脑卒中病灶数+LncRNA CRNDE)评估颈动脉狭窄性AIS患者预后的效能,高于LncRNA CRNDE、模型A(出血转化+脑卒中病灶数)(Z=2.603,P=0.009;Z=2.945,P=0.003)。 结论 LncRNA CRNDE与颈动脉狭窄性AIS患者支架植入术后预后关系密切,检测血清LncRNA CRNDE表达有助于评估患者预后。

参考文献/References:

[1] 江 薇,翁艳秋,王晓燕,等. 救护模式对缩短缺血性脑卒中就诊至动脉穿刺时间的效果评价[J]. 介入放射学杂志, 2018, 27:89- 91.
[2] Chang CS, Su SL, Kuo CL, et al. Cyclophilin a: a predictive biomarker of carotid stenosis in cerebral ischemic stroke[J]. Curr Neurovasc Res, 2018, 15: 111- 119.
[3] Yang X, Lu J, Wang J, et al. A clinical study and meta- analysis of carotid stenosis with coexistent intracranial aneurysms[J]. J Clin Neurosci, 2018, 52: 41- 49.
[4] Wangqin R, Krafft PR, Piper K, et al. Management of de novo carotid stenosis and postintervention restenosis- carotid endar-terectomy:versus carotid artery stenting:a review of literature[J]. Transl Stroke Res, 2019, 10: 460- 474.
[5] Jolobe OMP. Mitigation of stroke risk in nonvalvular atrial fibrillation patients with high- grade carotid artery stenosis[J]. Am J Med Sci, 2018, 356: 578- 579.
[6] Yang L, Liu J, Qi G, et al. The middle- term outcome of carotid endarterectomy and stenting for treatment of ischemic stroke in Chinese patients[J]. Sci Rep, 2018, 8: 4697.
[7] Lin CM, Liu CK, Chang YJ, et al. Reversed ophthalmic artery flow following ischemic stroke: a possible predictor of outcomes following carotid artery stenting[J]. Neurol Res, 2019, 41: 132- 138.
[8] Dong Y, Chao L, Li D, et al. Enterprise stent for symptomatic complex intracranial atherosclerotic stenosis: safety and efficiency[J]. J Intervent Med, 2018, 1: 234- 239.
[9] 颜进项,孟 雷,钟良君,等. 支架技术在急性缺血性卒中合并颅内外动脉狭窄中的应用[J]. 中华神经外科杂志, 2018, 34:45- 49.
[10] 翟萌萌,王建平,余 列,等. 中性粒细胞与淋巴细胞比值对急性脑梗死患者预后的预测价值[J]. 中国脑血管病杂志, 2017,14:82- 86.
[11] 陈 欢,卓文燕,朱培培,等. 25- 羟基维生素D联合尿酸对缺血性脑卒中严重程度及早期预后的评估价值[J]. 中国实用神经疾病杂志, 2017, 20:3- 7.
[12] 徐 磊. 白藜芦醇抗动脉粥样硬化机制研究[J]. 中风与神经疾病杂志, 2018, 35:566- 568.
[13] Zhou Y, He X, Liu R, et al. LncRNA CRNDE regulates the proliferation and migration of vascular smooth muscle cells[J]. J Cell Physiol, 2019, 234: 1- 10.
[14] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组. 中国急性缺血性脑卒中诊治指南2014[J]. 中华神经科杂志, 2015, 48:246- 257.
[15] Chen F, Zhang L, Wang E, et al. LncRNA GAS5 regulates ischemic stroke as a competing endogenous RNA for miR- 137 to regulate the Notch1 signaling pathway[J]. Biochem Biophys Res Commun, 2018, 496: 184- 190.
[16] Zhang L, Luo X, Chen F, et al. LncRNA SNHG1 regulates cerebrovascular pathologies as a competing endogenous RNA through HIF- 1α/VEGF signaling in ischemic stroke[J]. J Cell Biochem, 2018, 119: 5460- 5472.
[17] Yang J, Gu L, Guo X, et al. LncRNA ANRIL expression and ANRIL gene polymorphisms contribute to the risk of ischemic stroke in the Chinese Han population[J]. Cell Mol Neurobiol, 2018, 38: 1253- 1269.
[18] Sun H, He L, Ma L, et al. LncRNA CRNDE promotes cell pro- liferation, invasion and migration by competitively binding miR- 384 in papillary thyroid cancer[J]. Oncotarget, 2017, 8: 110552- 110565.
[19] Chen Z, Yu C, Zhan L, et al. LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppres- sing miR- 384[J]. Am J Cancer Res, 2016, 6: 2299- 2309.
[20] Wei W, Li S, San F, et al. Retrospective analysis of prognosis and risk factors of patients with stroke by TOAST[J]. Medicine (Baltimore), 2018, 97: e0412.
[21] Xie D, Xiang W, Weng Y, et al. Platelet volume indices for the prognosis of acute ischemic stroke patients with intravenous thrombolysis[J]. Int J Neurosci, 2019, 129: 344- 349.
[22] Espitia O, Chatelais M, Steenman M, et al. Implication of molecular vascular smooth muscle cell heterogeneity among arterial beds in arterial calcification[J]. PLoS One, 2018, 13: e0191976.
[23] Grootaert M, Moulis M, Roth L, et al. Vascular smooth muscle cell death, autophagy and senescence in atherosclerosis[J]. Cardiovasc Res, 2018, 114: 622- 634.
[24] Hamczyk MR, Villa- Bellosta R, Gonzalo P, et al. Vascular smooth muscle- specific progerin expression accelerates athero- sclerosis and death in a mouse model of Hutchinson- Gilford progeria syndrome[J]. Circulation, 2018, 138: 266- 282.

备注/Memo

备注/Memo:
(收稿日期:2020- 11- 18)
(本文编辑:边 佶)
更新日期/Last Update: 2021-07-28